Amp Capital Investors LTD Halozyme Therapeutics, Inc. Transaction History

Amp Capital Investors LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $180,693 - $218,034	-4,697 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $182,431 - $241,003	4,697 New	4,697 $213,000
Q2 2018 Aug 13, 2018	SELL	$16.87 - $20.3 $255,799 - $307,808	-15,163 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $258,680 - $321,455	15,163 New	15,163 $287,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.